# A Study Designed to Determine if the Drugs Albuterol (Salbutamol) and Fluticasone Have an Effect on the Pharmacokinetics of the Investigational Product Technosphere® Insulin Inhalation Powder in Healthy Volunteers

> **NCT00674050** · PHASE1 · COMPLETED · sponsor: **Mannkind Corporation** · enrollment: 13 (actual)

## Conditions studied

- Diabetes Mellitus
- Healthy Subjects

## Interventions

- **DRUG:** Technosphere Insulin (TI) Inhalation Powder
- **DRUG:** Albuterol (Salbutamol)
- **DRUG:** Fluticasone

## Key facts

- **NCT ID:** NCT00674050
- **Lead sponsor:** Mannkind Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-09
- **Final completion:** 2008-10
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2012-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00674050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00674050, "A Study Designed to Determine if the Drugs Albuterol (Salbutamol) and Fluticasone Have an Effect on the Pharmacokinetics of the Investigational Product Technosphere® Insulin Inhalation Powder in Healthy Volunteers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00674050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*